Japan recalls Kaketsuken products after discovering violations and cover-up

Regulators are recalling more than half a dozen products produced by Japan's Chemo-Sero-Therapeutic Research Institute, known as Kaketsuken, after it acknowledged that for more than 40 years it has violated some regulations having to do with using additives and production methods that had not been authorized by the government. It devised a cover-up plan, according to a recent report, that now has been brought to light. The company has done work for Daiichi Sankyo and Takeda Pharmaceuticals on seasonal flu shots and other products and has a wide reach in the country and a series of licensing pacts with companies abroad. More from FiercePharmaAsia

Suggested Articles

With generics at the gates, Novartis’ Gilenya secured a breath of fresh air—and protection for its blockbuster sales—with a federal injunction.

Akorn has been slammed with another FDA warning letter even as it is in the process of renegotiating its loans with lenders.

Horizon Therapeutics is preparing for the potential launch of inflammatory eye drug teprotumumab with team building.